6次资产甩卖!净利跌超20%!“瘦身自救”的华润医药,是失意还是转型?

E药经理人
Dec 06, 2025

一方面是贯穿全年的折价清仓,另一方面是核心利润两位数下滑——2025 年的华润医药,正经历一场备受瞩目的“中场调整”。撰文|王昭媛年末收官之际,华润医药再添一笔资产出售。12月2日,华润医药以公开挂牌方式将旗下安徽金太阳生化药业有限公司92%股权出售,成交价是首次挂牌价的90%。今年以来,面对内外环境的持续压力,华润医药展开了一系列资产剥离行动。从年初到年末,公司已累计出售6家子公司股权,且多数为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10